Biological Markers – Predictors of No-Reflow Phenomenon After Primary PCI in Patients with ST-Segment Elevation Myocardial Infarction

Pantea-Roșan, Larisa Renata; Moisi, Mădălina Ioana; Pantea, Vlad Alin; Ţica, Otilia; Ţica, Ovidiu; Babeș, Katalin; Polojintef-Corbu, Dorina; Popescu, Mircea Ioachim

doi:10.2478/inmed-2019-0065

Abstract

Lipid parameters along with the biological markers of myocardial necrosis play an essential role in highlighting the patient at an increased risk of developing the no-reflow phenomenon from an STEMI. This phenomenon is due to primary PCI failure of blood flow in the coronary microcirculation, although the artery involved in the infarction is disintegrated.

References

1. Ginghină C., Mateescu A, Muraru D. Ateroscleroza. Călin C. Infarctul miocardic cu supradenivelare de segment ST. În: Ginghină C. Mic tratat de Cardiologie, Ed. a 2-a, rev. și adăug., București: Edit. Academiei Române, 2017, 327-379
Search in Google Scholar Back to article
2. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM., Binno S. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal 2016; 29(37):2315-238110.1093/eurheartj/ehw106498603027222591
Search in Google Scholar Back to article
3. Morrow D. A., Cannon C. P., Jesse R. L., Newby L. K., Ravkilde J., Storrow A.B., Wu A. H. B., Christenson R. H.. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes. Circulation 2007; 13(115):e356-e37510.1161/CIRCULATIONAHA.107.18288217384331
Search in Google Scholar Back to article
4. Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg Ph G, Wijns W, Bassand J, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW,Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon J, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh Ph, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Bøtker HE, Bozkurt B, Bugiardini R, Cannon C, Lemos J, Eberli FR, Escobar E, Hlatky M, James S Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, StoreyRF, Taubert KA, Vranckx P, Wagner DR. 2012ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Third universal definition of myocardial infarction, European Heart Journal, 2012, 20(33)2551-256710.1093/eurheartj/ehs18422922414
Search in Google Scholar Back to article
5. Neufeld H.N., Rabinowitz B., Clejan S., Doman J.. Isoenzymes of creatine phosphokinase in acute myocardial infarction. Angiology 1977; 12(28):853-6410.1177/000331977702801206603094
Search in Google Scholar Back to article
6. Skyschally A, Leineweber K, Gres P, Haude M, Erbel R, Heusch G. Coronary microembolization, Basic Research in Cardiology 2006, 5(101) 373-38210.1007/s00395-006-0616-116915530
Search in Google Scholar Back to article
7. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal, 2016, 39(37):2999-305810.1093/eurheartj/ehw27227567407
Search in Google Scholar Back to article
8. Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg Ph G, Wijns W, Bassand J, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW,Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon J, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh Ph, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Bøtker HE, Bozkurt B, Bugiardini R, Cannon C, Lemos J, Eberli FR, Escobar E, Hlatky M, James S Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, StoreyRF, Taubert KA, Vranckx P, Wagner DR. 2012ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Third universal definition of myocardial infarction, European Heart Journal, 2012, 20(33)2551-256710.1093/eurheartj/ehs184
Search in Google Scholar Back to article
9. Tatu-chiţoiu G, Tatu-Chiţoiu A, Lăcău S. Electrocardiograma în reperfuzia miocardică, Edit. Medicală Antaeus, București, 2014, pag. 333
Search in Google Scholar Back to article
10. Durante A, Camici PG. Novel insights into an “old” phenomenon: the no reflow. International journal of cardiology 2015; 187:80-27310.1016/j.ijcard.2015.03.35925838230
Search in Google Scholar Back to article
11. Celik T, Balta S, Mikhailidis DP, Ozturk C, Aydin I, Tok D, Yildirim AO, Demir M, Iyisoy A. The Relation Between No-Reflow Phenomenon and Complete Blood Count Parameters. Angiology 2017; 5(68):381-38810.1177/000331971665919327418628
Open DOI Search in Google Scholar Back to article

Biological Markers – Predictors of No-Reflow Phenomenon After Primary PCI in Patients with ST-Segment Elevation Myocardial Infarction

Abstract

Paradigm

My account